Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Cancer
Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Cancer
Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Cancer
Submitted by
admin
on April 18, 2010 - 12:19pm
Source:
Medical News Today
News Tags:
Circadian Technologies
VGX-100
VEGF-C growth factor
cancer
Docetaxel
Avastin
Headline:
Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Cancer
Do Not Allow Advertisers to Use My Personal information
